#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mastocytosis Gestational trophoblastic tumour Chronic graft versus host disease in liver Epileptic encephalopathy Burkitt's lymphoma Hypereosinophilic syndrome Cystic fibrosis gastrointestinal disease Hyperoxaluria Congenital growth hormone deficiency Oesophageal atresia Extraskeletal ossification Antiphospholipid syndrome Ovarian epithelial cancer Juvenile chronic myelomonocytic leukaemia Osteosarcoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Synovial sarcoma recurrent – Life with Disease Andersen-Tawil syndrome – Treatment Leiomyosarcoma Advanced systemic mastocytosis – Basic Information Vascular malformation – Life with Disease Usher’s syndrome – Basic Information Osteosarcoma metastatic Cholangitis sclerosing – Life with Disease Epidermolysis bullosa – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM IBANDRONATE Iodine (123I) Iobenguane Acp-017 Heparin Sodium Mebufotenin Alisertib Sodium Mannitol Csm-Gw Abbv-668 Bi 1819479 Escitalopram Paclitaxel Festuca Elatior Pollen Extract Magnesium Chloride Diltiazem Hydrochloride Plerixafor Cinchocaine Hydrochloride Elinzanetant IMEROPRUBART Ecoo15 More therapies…

    Learn about Your Condition

    Neonatal asphyxia Heart transplant Cardiac failure congestive Noonan syndrome Anal cancer Thermal burn Supranuclear palsy Hand dermatitis Morning sickness Cerebral palsy Colon cancer stage IV Myasthenia gravis Papulopustular rosacea Venous thrombosis Hyperplasia adrenal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clintrial s.r.o.

Clintrial s.r.o.

Pocernicka 1427/16, Strasnice, Prague, 100 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atogepant
    Czechia Denmark France Germany Hungary Italy +3

  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Czechia Germany Italy Romania Slovakia Spain

  • Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Dc-806
    Czechia Germany Hungary Poland Spain

  • Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study on the Effects of Mebufotenin (GH001) for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Mebufotenin
    Czechia Germany Ireland Poland Spain
Previous Page
1 … 6 7 8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!